首页 | 官方网站   微博 | 高级检索  
     

冠心病介入治疗前后血清白细胞介素18、可溶性CD40L和超敏C反应蛋白变化与早期并发症的关系
引用本文:晋群,秦永文,李晓燕,许琳,张洪明.冠心病介入治疗前后血清白细胞介素18、可溶性CD40L和超敏C反应蛋白变化与早期并发症的关系[J].中国临床医学,2011,18(6):785-787.
作者姓名:晋群  秦永文  李晓燕  许琳  张洪明
作者单位:1. 济南军区总医院心内科,山东济南,250031
2. 第二军医大学附属长海医院心内科,上海,200433
摘    要:目的:通过检测经皮冠状动脉介入治疗(PCI)术前、术后血清白细胞介素18(IL-18)、可溶性CD40L(sCD40L)和超敏C反应蛋白( hsCRP)的水平,探讨其与冠心痛PCI术后早期并发症之间的关系.方法:选择经冠状动脉造影确诊的冠心病患者85例,其中不稳定型心绞痛患者44例,急性心肌梗死患者41例;选择40例冠状动脉造影正常者作为对照组.采用双抗体夹心酶联免疫吸附分析(ELISA)法测定PCI术前术后血清IL-18、CD40L和hsCRP水平,同时通过对PCI术中、术后30 d早期并发症的观察,探讨PCI手术前后血清IL-18及hsCRP水平与PCI早期并发症之间的关系.结果:85例患者PCI术后心脏早期并发症总发生率为9.4%(8/85),其中AMI组14.6%(6/41)显著高于不稳定型心绞痛(UA)组4.5%(2/44)(P<0.05),术后IL-18、CD40L和hs-CRP水平差值也显著高于无早期并发症患者(P<0.05),发生早期并发症者术前IL-18、CD40L及hsCRP水平及术后差值均显著高于未发生并发症者(P<0.05).结论:PCI术可能在短期内触发并加重了冠状动脉炎性反应,IL-18、CD40L和hsCRP有可能作为早期并发症的预测因子.

关 键 词:冠心痛  白细胞介素18  CD40L  超敏C反应蛋白  经皮冠状动脉介入治疗  早期并发症

Investigation of the Effects of PCI on Serum IL-18,sCD40L and hs-CRP Levels in Patients with Coronary Artery Disease and the Relationship between Early Complications
JIN Qun , QIN Yongwen , LI Xiaoyan , XU Lin , ZHANG Hongming.Investigation of the Effects of PCI on Serum IL-18,sCD40L and hs-CRP Levels in Patients with Coronary Artery Disease and the Relationship between Early Complications[J].Chinese Journal Of Clinical Medicine,2011,18(6):785-787.
Authors:JIN Qun  QIN Yongwen  LI Xiaoyan  XU Lin  ZHANG Hongming
Affiliation:1.Department of Cardiology,General Hospital of Jinan Military Region,Jinan 250031,China;2.Department of Cardiology,Changhai Hospital,Second Military Medical University,Shanghai 200433,China
Abstract:Objective:To explore the changes of serum levels of IL-18,sCD40L and hsCRP in coronary artery disease after PCI and to investigate the prognostic value of IL-18 and hsCRP for early complications after PCI.Methods:A total of 85 patients with ACS which including 44 patients with UA and 41 patients with AMI were enrolled.All patients were treated by PCI.The pre-and pro-procedural levels of serum IL-18 and hsCRP were tested to investigate the changes of serum levels of IL-18, sCD40L and hsCRP and the prognostic value for early complications after PCI.Results:Incidence of the early complications was 9.4%(8/85) in the whole population,incidence in AMI 14.6%(6/41) was higher than that in UA 4.5%(2/44)(P〈0.05). The levels of serum IL-18,sCD40L and hsCRP of patients of early complications before PCI was higher than those without early complications before PCI(P〈0.05).The increase of serum IL-18,sCD40L and hsCRP of patients of early complications after PCI was higher than those without early complications after PCI(P〈0.05).Conclusions:The earlier inflammation reaction in coronary artery may be triggered and aggravated by PCI.The occurrence of early complications after PCI may concerned with inflammatory responses.IL-18,sCD40L and hsCRP may provide more powerful predictors of early complications after PCI.
Keywords:Coronary heart disease  IL-18  CD40L  hsCRP  Percutaneous coronary intervention  Early complications
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号